Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

2D model showing how the pluripotent stem cells react to human relevant doses of cadmium over 8 days. From the control in the first panel, to the last panel, researchers can see how the differentiation to cardiomyocytes is inhibited with different doses of cadmium.

News | Congenital Heart

New 3D Model Shows How Cadmium Exposure May Affect Heart Development

November 2, 2022 — Researchers have developed a three-dimensional model that shows how exposure to cadmium might lead ...

November 02, 2022

News | VIVA

VIVA Foundation Symposium presents Clinical Trial Findings

November 2, 2022 — The second round of late-breaking clinical trial results were announced at VIVA22 on Nov. 1 in Las ...

November 02, 2022

News | VIVA

The VEINS/VIVA 2022 Top Awards Recognize Leaders in Vascular Medicine

November 2, 2022 — A number of awards of distinction were presented during The VEINS (Venous Endovascular INterventional ...

November 02, 2022

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: What Viewers Were Reading in October

Here is what you and your colleagues found to be most interesting in the fields of diagnostic and interventional ...

November 01, 2022

An artist's rendering shows how a new pacemaker, designed by a UArizona-led team of researchers, is able to envelop the heart. The wireless, battery-free pacemaker could be implanted with a less invasive procedure than currently possible and would cause patients less pain. Illustration credit: Philipp Gutruff

News | Atrial Fibrillation

Battery-Free, Light-Powered Pacemaker May Improve Quality of Life for Heart Disease Patients

October 31, 2022 — Atrial fibrillation – a form of irregular heartbeat, or arrhythmia – leads to more than 454,000 ...

October 31, 2022

Clinical study evaluates treatment for endovascular aortic arch repair

News | Endovascular Aortic Repair

UH Harrington Heart and Vascular Institute Performs First TRIOMPHE Study Case in Northeast Ohio

October 26, 2022 — Thousands of people have new hope for treatment of thoracic aortic arch disease and University ...

October 26, 2022

Alex Carll, assistant professor in the UofL Department of Physiology, front, with Matthew Nystoriak, associate professor of medicine. (UofL Photo)

News | Atrial Fibrillation

UofL Researchers Discover E-Cigarettes Cause Cardiac Arrhythmias

October 26, 2022 — A new study from University of Louisville researchers in the Christina Lee Brown Envirome Institute ...

October 26, 2022

Analysis of randomized controlled trial data shows non-Caucasian high-risk PCI patients significantly benefit from Impella-support

News | Intra-Aortic Balloon Pumps (IABP)

Abiomed Creates Patient Assistance Program to Address Disparities in Healthcare

October 26, 2022 — Abiomed (Nasdaq: ABMD) announces a new program to address healthcare disparities in underserved ...

October 26, 2022

Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated announced submission of pivotal clinical data from the AcQForce Flutter trial

News

Acutus Medical Announces Submission of Premarket Approval Application for AcQBlate Force Sensing Ablation Catheter and System

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

October 24, 2022

CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly selective, once daily, oral small molecule inhibitor of aldosterone synthase, in the journal Hypertension Research.

News | Hypertension

CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension Research

October 24, 2022 — CinCor Pharma, Inc. announced the publication of Phase 1 clinical data for baxdrostat, a highly ...

October 24, 2022

Abiomed announced the U.S. Food and Drug Administration (FDA) has accepted and closed the post-approval study reports related to the pre-market approvals (PMA) for Impella heart pumps.

News | Cardiogenic Shock

Abiomed Successfully Completes All Impella Post-Approval Studies for High-Risk PCI, Cardiogenic Shock, Post-Cardiotomy Cardiogenic Shock and Right Heart Failure

October 21, 2022 — Abiomed announced the U.S. Food and Drug Administration (FDA) has accepted and closed the post ...

October 21, 2022

People with cardiovascular disease still have a high burden of risk factors for severe COVID

News | Coronavirus (COVID-19)

Smoking, Diabetes and Obesity - Not Preexisting Heart Disease - Bigger Risk of COVID-19 Death, Study Finds

October 17, 2022 — A national study suggests that risk factors for cardiovascular disease, such as age, smoking and ...

October 17, 2022

Significant findings from the highly-anticipated EPIC-STEMI study were presented during a late-breaking scientific session at the recent Transcatheter Cardiovascular Therapeutics (TCT) 2022 Annual Symposium in Boston, MA.

Feature | TCT | Christine Book

Dramatic Cholesterol Reduction from PCSK9 Inhibitor Achieved in EPIC-STEMI Trial

October 17, 2022 — Significant findings from the highly-anticipated EPIC-STEMI study were presented during a late ...

October 17, 2022

The HELIOSTAR Balloon Ablation Catheter's unique one-shot balloon technology enables pulmonary vein isolation in 12 seconds, with customized energy delivery and one integrated 3D mapping solution

News | EP Lab

Biosense Webster Launches HELIOSTAR in Europe, the First Radiofrequency Balloon Ablation Catheter, Enabling Physicians to Perform More Efficient Cardiac Ablations

October 14, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch of ...

October 14, 2022

Heart Initiative, the sponsor of the STRONG-HF (Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP testinG, of Heart Failure therapies) study, announced the premature termination of the trial.

News | Cardiovascular Clinical Studies

STRONG-HF Study in Patients Admitted for Acute Heart Failure (HF) Terminated Early for Superior Efficacy

October 14, 2022 — Heart Initiative, the sponsor of the STRONG-HF (Safety, Tolerability and efficacy of Rapid ...

October 14, 2022